Vaccination News Home Page

http://www.lifeclinic.com/healthnews/article_view.asp?story=23369

Italy region mulls mass vaccination for meningitis

 

Last Updated: 2002-12-11 13:00:45 -0400 (Reuters Health)

FLORENCE, Italy (Reuters Health) - Health authorities in northern Italy are considering a mass vaccination programme against meningitis, after an upsurge of the disease in Lombardy.

"There is no reason to dramatize: so far the recorded cases are within the norm. But if more cases are reported in the next days, we will evaluate the possibility of a vaccination for people at risk and children," Dr. Vittorio Carreri, director of the Lombardy Region Health Prevention Unit, told Reuters Health.

Meningitis is an inflammation of the membranes that surround the brain and spinal cord, usually caused by a virus or bacterium. Symptoms include a high fever, severe headache and neck stiffness.

Bacterial meningitis is a serious, potentially fatal condition. Antibiotics are an effective treatment, but the infection can damage the brain and have long-term complications such as hearing loss and speech problems.

Despite the launch of a meningitis C vaccination campaign in September in Lombardy, fear of the infection has spread in the region around Milan.

In the villages of Abbiategrasso and Magenta, 6 kilometres away from Milan, seven cases have been recorded in a month. The disease was fatal in the case of a 15-year-old boy.

The specific pathogen responsible for these cases has yet not been identified. Test results will be available in the next few days, Carreri said.

According to data from the National Health Institute, starting from 1994 most bacterial meningitis cases in Italy were due to Streptococcus pneumoniae. The next most common pathogen was Neisseria meningititis.

Last year Lombardy recorded 187 cases of meningitis.


 

Copyright © 2001 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.


Send This Page to a Friend Printer Friendly Page
Save to My Article List Reuters HealthNews
 
Technical problems with the web site? E-mail technicalhelp@lifeclinic.com
Comments about the web site? E-mail comments@lifeclinic.com
Health related questions? Ask the Expert

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.